Industry Insight
Information, Observation & Analysis
From minor violations to major safety concerns, sometimes medicines must be removed from the marketplace. Here's the lowdown on how it's handled.
Today, the most pressing patient safety issues are the urgency of address the proliferation of both prescription and illicit drugs, the ability of the U.S. Food and Drug Administration to monitor the safety of prescription medicines after they enter the market and the need to accurately track the number of deaths caused by medical mistakes.
The shortcomings of AAT augmentation therapy for AATD are currently the targets of a diverse range of new investigational therapies.
As chronic diseases continue to rise, high-touch, personalized care improves patient access and adherence to life-changing medications.
The lingering effects of viral infections are not well-understood, but long COVID is helping shed light on the mysterious phenomenon, particularly in patients with chronic fatigue syndrome.
With influenza apparently returning with a vengeance this season, the Centers for Disease Control and Prevention is once again alerting the public that vaccination is the most effective way to prevent infection from and to minimize risk of severe symptoms and hospitalization for serious flu-related complications.
While the COVID-19 pandemic is "officially over," hospitalizations and deaths continue, many of which are due to the myths continuing to circulate about this deadly virus.
Research into effective treatments for this complicated disease is elusive — and necessary.
The pandemic made a troubling mental health trend in children much worse. What's being done to help them?
While a cure for Alzheimer’s remains elusive, new diagnostic tools and treatment options are improving patient quality of life.
Exciting new developments in gene therapy and genome editing show promise for treating a variety of genetic diseases.
Do the advantages of virtual care outweigh the drawbacks? Patients seem to think so.